Article

Open Access  |  Correction
Hepatoma Res 2019;5:22. 10.20517/2394-5079.2019.017 © The Author(s) 2019.

Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B

Views: 949 |  Downloads: 695 |  Cited:  0

1Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

2Department of Radiology, Abdominal Imaging Division, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

3Department of Pathology, Anatomy, & Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

4Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

5Liver Disease prevention Center, Division of Gastroenterology and Hepatology Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

Correspondence Address: Dr. Hie-Won Hann, FAASLD, Professor of Medicine, Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. E-mail: hie-won.hann@jefferson.edu

© The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

The Case Report was published on 21 Jun 2019.

The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction:

Conflict of Interest:

Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences.

Ralph Zinner: Bristol Myers Squibb, Merck

Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest.

We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.

Cite This Article

OAE Style

Block PD, Shinn BJ, Roth CG, Baliff JP, Zinner RG, Hann HW. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma Res 2019;5:22. http://dx.doi.org/10.20517/2394-5079.2019.017

AMA Style

Block PD, Shinn BJ, Roth CG, Baliff JP, Zinner RG, Hann HW. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma Research. 2019; 5: 22. http://dx.doi.org/10.20517/2394-5079.2019.017

Chicago/Turabian Style

Block, Peter D., Brianna J. Shinn, Christopher G. Roth, Jeffrey P. Baliff, Ralph G. Zinner, Hie-Won Hann. 2019. "Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B" Hepatoma Research. 5: 22. http://dx.doi.org/10.20517/2394-5079.2019.017

ACS Style

Block, PD.; Shinn BJ.; Roth CG.; Baliff JP.; Zinner RG.; Hann H.W. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma. Res. 2019, 5, 22. http://dx.doi.org/10.20517/2394-5079.2019.017

Views
949
Downloads
695
Citations
0
Comments
0
0

Related

Open Access Systematic Review
Hepatic venous pressure gradient in hepatic resection for hepatocellular carcinoma
Available online: 20 Nov 2023
Open Access Review
Targeted mutation-based therapy for intrahepatic cholangiocarcinoma
Available online: 15 Nov 2023
Open Access Review
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts
Available online: 5 Nov 2023
Open Access Review
The role of exosomes in therapeutic resistance of hepatocellular carcinoma
Available online: 29 Oct 2023
Open Access Original Article
Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers’ perspectives
Available online: 29 Oct 2023
Open Access Review
Treatment of intrahepatic cholangiocarcinoma: evidence for the role of percutaneous ablation
Available online: 23 Oct 2023
Open Access Review
Trans-arterial chemoembolization and radioembolization for treatment of intrahepatic cholangiocarcinoma
Available online: 12 Oct 2023
Open Access Review
Strategy for ERCP stenting in cholangiocarcinoma
Available online: 25 Sep 2023
Open Access Review
Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma
Available online: 22 Aug 2023
Open Access Review
Advanced and emerging radiation therapy approaches for intrahepatic cholangiocarcinoma
Available online: 17 Aug 2023

Comments

Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.

0
Cite This Article 1 clicks
Commentary 0 comments
Like This Article 0 likes
Share This Article
Scan the QR code for reading!
See Updates
Contents
Figures
Related
Hot Topics
Hepatocellular carcinoma | HCC | Liver Cancer | Liver tumors | Hepatoblastoma | Cholangiocarcinoma | Nonalcoholic fatty liver disease | Nonalcoholic steatohepatitis | Hepatitis B; Hepatitis C | Immunotherapy | Systemic treatment | Liver transplantation | Liver resection | Surgical | Management | Surveillance | Epidemiology | Molecular mechanisms | Tumor microenvironment | Biomarker | Stem cell |
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/